Pinsent Masons expands Life Sciences Group with team hire

18 Feb 2013 | 09:15 am | 1 min. read

International law firm Pinsent Masons has boosted its Life Sciences group with the appointment of a four-strong Partner team.

The team of Paul Ranson, Allistair Booth, Stuart Richards and Charles Waddell - has a market-leading reputation for life sciences IP, regulatory and transactional work. 

They join a formidable Life Sciences team at Pinsent Masons, led by life sciences patent litigator Clare Tunstall, and complete the firm's full-service offering across the sector. 

Paul Ranson is a well-known figure in the Life Sciences world having previously headed the Healthcare group at Simmons & Simmons.

Allistair Booth and Stuart Richards work across corporate, commercial and non-contentious IP matters in the sector. 

Charles Waddell is a well known corporate finance specialist in the sector. His primary focus is advising in the biotechnology and medtech sectors on equity raisings, mergers and acquisitions and other corporate transactions..  The team, which is ranked in the top tier of Life Sciences advisers by leading independent legal directories Chambers and Legal 500, has a strong client base of pharmaceutical, drug delivery, biotech and, medtech companies.

They arrive from the London office of Canadian firm Fasken Martineau and will bring the total number of lateral hires announced by Pinsent Masons in 2013 to seven.

David Ryan, Managing Partner of Pinsent Masons, says:

"We have started the year strongly, with significant hires into those areas where we see the greatest opportunity for growth domestically and internationally, and will continue to make investments in line with our sector-focused strategy.

"These appointments ensure that Pinsent Masons' offering in the Life Sciences sector is unrivalled, providing in depth expertise on business critical issues as well and the ability to deploy 'go to' partner specialists on all business as usual areas.We are therefore delighted that Paul and his colleagues are joining us.”

Key Contacts

Clare Tunstall

Clare Tunstall

Partner, Head of IP & Life sciences

View Profile

Latest press releases

Show me all press releases

Pinsent Masons advises NTR plc on 54MW portfolio of co-located solar and battery storage projects in Ireland

Multinational law firm Pinsent Masons has advised NTR PLC on the acquisition of a 54MW portfolio of co-located solar and battery storage projects in County Wexford, Ireland, from renewable energy developer RES.

Pinsent Masons advises on Four Seasons Care Homes portfolio migration

Multinational law firm Pinsent Masons has advised propco investor LDC Care Homes and its asset and investment manager Elevation Advisors on the migration of a care homes portfolio from Four Seasons Health Care Group (FSHC) to new operators.

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

People who viewed this press release also viewed

Show me all press releases

Pinsent Masons advises Teva Pharmaceuticals on €84m sale of its consumer healthcare brand portfolio to Karo Pharma AB.

Multinational law firm Pinsent Masons has advised Teva Pharmaceuticals’ subsidiary, Actavis Group PTC, on the successful €84m sale of a suite of consumer healthcare products to Karo Pharma AB (Karo).

Pinsent Masons appointed to UK Government Trade Law Panel

Multinational law firm Pinsent Masons has been appointed to the UK Government's new Trade Law Panel in an international consortium with BakerHostetler in the USA, and Fasken in Canada, to advise on international trade law disputes.

Pinsent Masons advises on commercial close of four new dialysis clinics in Uzbekistan

Multinational law firm Pinsent Masons has advised on the commercial close of four dialysis centres – a pathfinder public private partnership (PPP) implemented in Uzbekistan.

For all media enquiries, including arranging an interview with one of our spokespeople, please contact the press office on

+44 (0)20 7418 8199 or 

Location contacts